ATA925774A - Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen - Google Patents

Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen

Info

Publication number
ATA925774A
ATA925774A AT925774A AT925773A ATA925774A AT A925774 A ATA925774 A AT A925774A AT 925774 A AT925774 A AT 925774A AT 925773 A AT925773 A AT 925773A AT A925774 A ATA925774 A AT A925774A
Authority
AT
Austria
Prior art keywords
dihydropyridines
diamino
producing new
producing
new
Prior art date
Application number
AT925774A
Other languages
German (de)
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA925774A publication Critical patent/ATA925774A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT925774A 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen ATA925774A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATA925774A true ATA925774A (de) 1975-05-15

Family

ID=5838037

Family Applications (3)

Application Number Title Priority Date Filing Date
AT925774A ATA925774A (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT197373A AT324338B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT925774*7A AT327904B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT197373A AT324338B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT925774*7A AT327904B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen

Country Status (24)

Country Link
JP (2) JPS5626659B2 (el)
KR (1) KR780000119B1 (el)
AT (3) ATA925774A (el)
BE (1) BE796279A (el)
BG (2) BG22815A3 (el)
CA (1) CA988524A (el)
CH (2) CH577473A5 (el)
CS (2) CS182781B2 (el)
DD (1) DD106833A5 (el)
DE (1) DE2210687C3 (el)
DK (1) DK136061C (el)
ES (1) ES412323A1 (el)
FI (1) FI55996C (el)
FR (1) FR2181789B1 (el)
GB (1) GB1379005A (el)
HU (1) HU167089B (el)
IE (1) IE37370B1 (el)
IL (1) IL41664A (el)
LU (1) LU67147A1 (el)
NL (1) NL7303137A (el)
PL (2) PL92078B1 (el)
RO (2) RO63068A (el)
SE (1) SE384208B (el)
ZA (1) ZA731501B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (el) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
CH580589A5 (el) 1976-10-15
SE384208B (sv) 1976-04-26
ZA731501B (en) 1973-11-28
CA988524A (en) 1976-05-04
KR780000119B1 (en) 1978-04-15
ES412323A1 (es) 1976-01-01
DE2210687A1 (de) 1973-09-20
FI55996B (fi) 1979-07-31
DE2210687B2 (de) 1980-09-04
IE37370B1 (en) 1977-07-06
BG22815A3 (bg) 1977-04-20
FR2181789B1 (el) 1976-12-03
JPS48103579A (el) 1973-12-25
CH577473A5 (el) 1976-07-15
RO61192A (el) 1976-09-15
IL41664A (en) 1976-01-30
NL7303137A (el) 1973-09-10
JPS5911584B2 (ja) 1984-03-16
HU167089B (el) 1975-08-28
LU67147A1 (el) 1973-05-22
DK136061C (da) 1978-01-02
RO63068A (el) 1978-05-15
CS182781B2 (en) 1978-05-31
AT324338B (de) 1975-08-25
BE796279A (fr) 1973-09-05
FR2181789A1 (el) 1973-12-07
AT327904B (de) 1976-02-25
BG20583A3 (bg) 1975-12-05
GB1379005A (en) 1975-01-02
DD106833A5 (el) 1974-07-05
IL41664A0 (en) 1973-05-31
DE2210687C3 (de) 1981-09-24
JPS5626659B2 (el) 1981-06-19
DK136061B (da) 1977-08-08
FI55996C (fi) 1979-11-12
IE37370L (en) 1973-09-06
PL92078B1 (el) 1977-03-31
PL89256B1 (el) 1976-11-30
JPS5699460A (en) 1981-08-10
CS182792B2 (en) 1978-05-31

Similar Documents

Publication Publication Date Title
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT342556B (de) Verfahren zur herstellung von neuen 1,2,2,2-tetrafluorathylathern
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT331806B (de) Verfahren zur herstellung von neuen 1,2,4-triazin-di-n-oxiden(1,4)
AT342564B (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT327902B (de) Verfahren zur herstellung von neuen 3,4-dihydropyridonen
AT327407B (de) Verfahren zur herstellung von neuen benzomorphanderivaten
AT326842B (de) Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten
AT328459B (de) Verfahren zur herstellung von neuen 1,3,5-triazinen
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT326145B (de) Verfahren zur herstellung von neuen phosphonoureidoverbindungen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT322739B (de) Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT331203B (de) Verfahren zur herstellung von 1,2-dichlorathan
AT328631B (de) Verfahren zur herstellung von neuen 9,10-seco-ostran-derivaten
AT323345B (de) Verfahren zur herstellung von neuen 15 alfa, 16 alfa-methylen-5 alfa-androstanen
AT342025B (de) Verfahren zur herstellung von neuen 2- (alfa-di-substituierten-aminobenzyl) -propandiolen- (1,3)
AT335627B (de) Verfahren zur herstellung von neuen 3',4'-anhydro-alfa,l-talomethylosiden
AT327206B (de) Verfahren zur herstellung von neuen nitrochinazolinonen
AT331422B (de) Verfahren zur herstellung von neuen digitoxigenin-l-rhamnosid-cyclocarbonaten
ATA793175A (de) Verfahren zur herstellung von neuen n-organo-n-phosphonmethyl-glycin-n-oxiden
ATA521876A (de) Verfahren zur herstellung von neuen ketophos- phonaten